Gsk Share Discussion Threads

[andyadvfn1] 28/9/2017 08:48

Earnings not enough to warrant a divi increase.

[gbh2] 28/9/2017 07:49

I've not held or followed for a while, any reason for no increase in the dividend, has there been a "Special" this year?

[ny boy] 28/9/2017 03:06

Top tips, yes I have a large holding in IMM too, nicely in profit but holding for the biggie next year fingers xxx'd

Back to GSK, on the move back to 1700p +

Nice divi too

Back to my holiday

Catch up later

[latics2] 27/9/2017 14:45

Monty is a no hoper. lol

[romeike] 27/9/2017 13:41

You guys think a huge company like GSK doesn't have a team in finance dedicated to managing and even benefiting from currency movements? All this short term focus on exactly what is happening with the currencies each day is ridiculous in the face of something that tends to balance out over time.

And I am really sorry to break it to you, but yes Monty is a moron and every post he makes is puerile vomit.

[montyhedge] 26/9/2017 08:15

Hope it works, hope it gets approval, hope is not my investment strategy. Rather pay more if all ok in two years time.

[top tips] 25/9/2017 13:06

IMMUPHARMA (IMM)

Potential blockbuster Lupuzor Phase III results due Q1 2018.

Only other similar drug Benlysta was bought out from HGSi by GSK in 2012 for $3.6 billion for 50% stake valuing Benlysta around $7 billion (and IMM's Lupuzor appears to be safer and more efficaceous than Benlysta).

$7 billion buyout of IMM gives £39.70 share price against current 51p, or 77+ bagger !!!

Potential blockbuster Lupuzor has 'Fast Track' and 'SPA' status from US FDA, so could be market launched in 2018.

Tim McCarthy (IMM's Chairman) 14/3/2017:

"There's going to be a fantastic return on investment for anybody who invests in ImmuPharma...This (Lupuzor) is going to be a multi-billion dollar drug, its as simple as that...This will absolutely be a multi-billion dollar drug."

4 min 40 sec.

[ny boy] 22/9/2017 14:53

Powering ahead now tks to May and her magnificent Brexit speech

[ny boy] 22/9/2017 12:05

Lol

No chance ..more like on the road to 1700p, dips being bought, insistutional buying.

[badtime] 22/9/2017 11:40

I thought this was supposed to be at 1400 by now

[ny boy] 21/9/2017 19:42

EI, patience, good quarterly divi to keep everyone happy, sub 1500p very attractive for capital growth too, vols picking up, won't take too much to see these back to 1700p but not that important when it comes. Fab multi national play with defensive qualities in times of market troubles.

I'm very happy.

[essentialinvestor] 21/9/2017 19:16

NY, you were saying the same 12 months ago!.

Good to see a bit of progress.

[tradermichael] 21/9/2017 15:27

Low volume though ..... ;0)

[ny boy] 21/9/2017 15:18

Flight to quality ahead of The Great Unwind, commencing 01 Oct

[ny boy] 21/9/2017 09:42

Monty did you miss the Barcs train?

Happy holding, a nice quarterly divi and I expect decent capital growth buying sub 1500p GLA

Some decent news flow due, not a bad blue chip for ones portfolio.

[essentialinvestor] 20/9/2017 12:58

Michael, agree, the fundamental newsflow could not have developed much better.

Attention will now begin to turn to the medium term pipeline.

The potential of closed triple is being underestimated imv.

[tradermichael] 20/9/2017 12:18

There's more to GSK than just currency movements ...... ;0)

[essentialinvestor] 20/9/2017 12:01

GBP has recovered from around that plunge low of 1.18,
that's a storming recovery.

Some of the recent £vUSD stremght might be a little overdone.

There is scope for some disappointment in the reaction to May's speech imv.

If GBP did push on towards 1.40 then it's fair to say GSK share price progress (short term)
is less likely.

[badtime] 20/9/2017 11:45

We have Monty on one side and NY Boy on the other ..nicely balanced :)

[badtime] 20/9/2017 11:44

Haven't seen anyone be rude to Monty ..and as regards right I think that's yet to come to fruition ..he may or others may ..we are all grown up and have to make our own decisions

[ny boy] 20/9/2017 11:24

Nice bear trap @ support, knocked a few out there lol

Strong recovery from here, ignore £ strength, this has been much higher when the £ was over 1.5 to US$

[tradermichael] 20/9/2017 08:23

Then that is the Stock Market for you, isn't it? We have to have bears and we have to have bulls to drive the prices.

As for calling it 'right', for most blue chip companies, there will always be those who project a lower price when the price is falling. Sooner or later they may be correct, and they often move their price down as their target is reached. Similarly, on a rising price there will be those who project a higher price and move it up as that price is reached. The professional 'analysts' do this more often than not.

The thing about bears that some people feel is irksome is the rhetoric that confirms their faith e.g. when 'good' news emerges and the price does not react, they often say 'the news was in the price' or introduce another downbeat pessimistic conclusion. At least bulls appear to hold an optimistic view of the world, so I'd rather adopt this approach rather than the doom and gloom scenario ...... ;0).

[unastubbs] 20/9/2017 03:21

From what I can see Monty has had it correct. There are quite a few blue sky holders on here who are letting their current position rule their thinking. I can easily foresee GSK going below 13.50 if the markets pull back - which they must at some point soon. He's at least polite in the face of some quite strong provocation - so give him a break guys. I would like to ask Monty - you've been bearish for a while here and your price target often reduces - which is fair if the market or circs change - your latest call is 13.95 but I would like to ask in all seriousness - at that level will you actually buy any shares? Also, you are negative on many stocks - are you at all positive on anything atm? I asked you this a year ago btw. I find you quite interesting - i always like a contrarian. I'd like to disagree with you though abt GSK being "like a bond" - I feel that the dividend is not nailed on beyond 2018. Debt is a big factor with this company and unless they come up with a big win in the laboratory i feel the dividend will be cut in line with the new policy... - ok guys thanks for reading, good luck and best wishes from Chiang Mai!